RoboFlask cell culture vessels fit in a standard microplate footprint. The flask provides greater than 20% additional cell growth area over a 75 cm 2 flask. The vessel is designed for fully integrated cell culture instrumentation such as the Tecan Cellerity System.
The V200 Stroke Rate Controller controls all FMI V-Series Variable Speed Metering Pumps. Pump speed settings can be adjusted either manually in 0.1% increments using an on-board digital potentiometer, or through an electronic 4-20 mA interface.
Culture cells on up to 4 slides at the same time with quadriPERM, which is offered for applications requiring culture of cells on industry standard size (26 × 76 mm) slides. A must for every lab handling cells on slides, the design facilitates media exchange, fixing, staining and even transport.
SofTouch Electronic Pipettes perform multiple liquid handling functions, including pipetting, reverse pipetting, multiple dispensing, sequenced dispensing, diluting, and mixing.
Mechanical pipettors m LINE (Biohit) pipettors feature low pipetting and tip ejection forces, light weight and ergonomic design. The units can be completely autoclaved, and tip cone filters prevent the contamination of the pipettor and samples.
Eppendorf Research Pro single and multichannel pipettes offer a variety of programmable application parameters. Display screen is set at a 45° angle for easy reference during use. All buttons and controls are large and accessible.
The Labcyte® Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nl (CV 5-50 nl <8%; 5-50 nl. "Touchless" transfer technology is based on focused acoustic energy.
The Drummond Pipet-Aid Elite facilitates fast, accurate, pipetting and allows easy, comfortable operation. The lightweight Elite features intuitive user-friendly programming functions and "Easy Touch" buttons.
By Mark Terry The U.S. Food and Drug Administration (FDA) is starting a new guidance initiative for the co-development of pharmacogenomic-based therapeutic drugs.
By Mark Terry Abbott Laboratories, Abbott Park, Ill., and Celera Genomics, Rockville, Md., have announced a strategic collaboration to develop and commercialize potential cancer treatments.
By Mark Terry On July 1, 2004, Charles River Laboratories International Inc., Wilmington, Mass., and Inveresk Research Group Inc., Cary, N.C., announced approval of a merger.
By Mark Terry Compugen Ltd., Tel Aviv, Israel, announced that it has spun off its chemistry division into a subsidiary, Keddem Biosciences Ltd., to be located in Ashkelon, Israel.
By Mark Terry Metastatic breast cancer is considered incurable with survival periods of less than two years. This poor prognosis is due to chemo- and radioresistance on the part of metastatic cancer cells.
By Catherine Shaffer The Wistar Institute, Philadelphia, has announced that a new imaging agent, NeutroSpec, has been approved by the FDA.